Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSD | P07339 | 1/20 | 0.37 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.32 |
| ▸ | KDM5C | P41229 | 1/20 | 0.32 |
| ▸ | PHF8 | Q9UPP1 | 1/20 | 0.32 |
| ▸ | KDM2A | Q9Y2K7 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CTDSP1 | Q9GZU7 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
| ▸ | LMNA | P02545 | 1/20 | 0.30 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | TERT | O14746 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18850905 | 0.94 | CTSD (0.41) | CTSDKDM4EKDM5CPHF8KDM2A | |
| Hydrochloric Acid SCHEMBL18824462 | 0.91 | CTSD (0.39) | CTSDKDM4EKDM5CPHF8KDM2A | |
| SCHEMBL17591541 | 0.83 | TSHR (0.46) | CTSDKDM4ETSHRCTDSP1ALDH1A1 | |
| Bromide SCHEMBL19439475 | 0.82 | TSHR (0.44) | CTSDKDM4ETSHRCTDSP1ALDH1A1 | |
| SCHEMBL9967921 | 0.80 | NPC1 (0.44) | CTSDKDM4EKDM5CPHF8KDM2A | |
| Bromide SCHEMBL9938364 | 0.79 | NPC1 (0.46) | CTSDCTDSP1ALDH1A1POLBTERT | |
| Hydrochloric Acid SCHEMBL9937783 | 0.79 | NPC1 (0.43) | CTSDCTDSP1ALDH1A1POLBTERT | |
| SCHEMBL13051491 | 0.73 | BBOX1 (0.39) | KDM4ETSHRCTDSP1HTT | |
| SCHEMBL24896646 | 0.72 | POLB (0.33) | POLBHTT | |
| SCHEMBL26577967 | 0.71 | KDM4E (0.39) | CTSDKDM4EALDH1A1POLBHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11794161-B1 | Reduced permeability microcapsules | TRUCAPSOL, LLC (US) | 2023-10-24 | — | — | US | disclosed |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | ALTER DOMUS (US) LLC | 2023-10-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11794161-B1 | Reduced permeability microcapsules | CHMP4B, NSF, ACR | CTSD 778/4885KDM4E 2666/4885KDM5C 2347/4885 |
| US-20230330615-A1 | MICROCAPSULES COMPRISING NATURAL MATERIALS | RCC1, SAMM50, LIPA | CTSD 2955/4885KDM4E 3016/4885KDM5C 1595/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.